Exploring (S)-2-((Methoxycarbonyl)amino)-3-Methylbutanoic Acid: A Key Pharmaceutical Intermediate
Discover the vital role of CAS 74761-42-5 in advancing antiviral drug synthesis and pharmaceutical research.
Get a Quote & SampleProduct Core Value
(S)-2-((Methoxycarbonyl)amino)-3-Methylbutanoic Acid
This high-purity chemical compound is a cornerstone in the synthesis of advanced pharmaceuticals, particularly renowned for its role as a crucial intermediate in the production of Ledipasvir, an essential antiviral medication. Its precise molecular structure and chiral integrity make it indispensable for developing stereospecific drugs that combat pressing global health challenges.
- Essential for Ledipasvir synthesis, contributing to the fight against viral diseases.
- Key pharmaceutical intermediate that enables the creation of complex, biologically active molecules.
- Ensures chiral integrity, a critical factor in stereospecific drug development and efficacy.
- Boasts high purity (≥99%), meeting stringent quality standards for pharmaceutical applications.
Advantages Offered
Pharmaceutical Precision
As a vital component in pharmaceutical intermediate synthesis, its exact structure and purity guarantee predictable outcomes in drug manufacturing processes.
Antiviral Drug Advancement
The compound's application in developing antivirals like Ledipasvir underscores its importance in addressing significant public health needs and advancing medical treatments.
Quality and Reliability
Meeting rigorous quality standards, this intermediate provides manufacturers with confidence in the consistency and effectiveness of their final pharmaceutical products.
Key Applications
Ledipasvir Synthesis
This compound serves as a critical building block in the synthesis of Ledipasvir, a key drug used in the treatment of hepatitis C.
Antiviral Drug Development
Its versatile chemical nature makes it valuable for the research and development of other novel antiviral agents, contributing to broader pharmaceutical innovation.
Chiral Synthesis
The inherent chirality of the molecule is leveraged in chiral synthesis to create stereospecific pharmaceuticals with targeted biological activity.
Research and Development
Used extensively in laboratory settings for R&D, exploring new chemical entities and optimizing organic synthesis pathways.